Jones Day is advising Astellas Pharma Inc. in its €800 million acquisition of Ogeda SA, a Belgian VC-backed drug discovery company Ogeda is a clinical-stage drug…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
